Rhinovirus News and Research

RSS
Rhinovira are the most common viral infective agents in humans, and a causative agent of the common cold (about 49.12159% of the cases of the common cold are caused by this virus). It is lytic in nature. There are over a 100 recognized types of rhinovira that differ based on their varying surface proteins.

Further Reading

Marinomed’s Antiviral polymer awarded Chinese patent

Marinomed’s Antiviral polymer awarded Chinese patent

Respiratory infections provide urban asthma clue

Respiratory infections provide urban asthma clue

Differences in viral illness patterns play a role in asthma development in urban, suburban children

Differences in viral illness patterns play a role in asthma development in urban, suburban children

New oral antiseptic spray effective in killing 99.9% of infectious airborne germs

New oral antiseptic spray effective in killing 99.9% of infectious airborne germs

Study identifies how RNA viruses hijack a host cell to multiply

Study identifies how RNA viruses hijack a host cell to multiply

Vitamin D may help fight childhood acute respiratory infections

Vitamin D may help fight childhood acute respiratory infections

Being a parent protects against cold: Study

Being a parent protects against cold: Study

Majority of rhinovirus infections are asymptomatic

Majority of rhinovirus infections are asymptomatic

No link between viral infections during infancy and wheezing in childhood

No link between viral infections during infancy and wheezing in childhood

Teva to invest in CDI for development of novel antiviral drugs

Teva to invest in CDI for development of novel antiviral drugs

Impact of colds and flu on school absenteeism, workplace and economy

Impact of colds and flu on school absenteeism, workplace and economy

New ‘cure-all’ antiviral method discovered

New ‘cure-all’ antiviral method discovered

Biota reports preliminary data from CS-8958 Phase III trial against influenza

Biota reports preliminary data from CS-8958 Phase III trial against influenza

Boosting immune response may cause cold-induced asthma flare-ups

Boosting immune response may cause cold-induced asthma flare-ups

Boosting immune response could increase inflammation

Boosting immune response could increase inflammation

NIAID awards Biota $2.9M grant for development of lead candidate for C. difficile

NIAID awards Biota $2.9M grant for development of lead candidate for C. difficile

FDA clears ITI's FilmArray RP assay for respiratory virus detection

FDA clears ITI's FilmArray RP assay for respiratory virus detection

Researchers manage to grow human rhinovirus in culture using sinus tissue

Researchers manage to grow human rhinovirus in culture using sinus tissue

Biota receives US$231 million BARDA contract to advance laninamivir development

Biota receives US$231 million BARDA contract to advance laninamivir development

Unique device eliminates cold and flu germs in eco-friendly way

Unique device eliminates cold and flu germs in eco-friendly way